Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04417036 |
|---|---|
| Brief Title: | This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS) (SEAL) |
| First Submitted : | May 29, 2020 |
| First Submitted that Met QC Criteria : | June 2, 2020 |
| First Posted : | June 4, 2020 |
| Last Update Submitted that Met QC Criteria : | April 13, 2023 |
| Last Update Posted : | April 18, 2023 |